Senti Biosciences Files 8-K
Ticker: SNTI · Form: 8-K · Filed: 2026-04-01T16:31:42-04:00
Sentiment: neutral
Topics: 8-K, SEC Filing, Reporting
TL;DR
Senti Bio filed an 8-K, no new info.
AI Summary
Senti Biosciences, Inc. filed an 8-K on April 1, 2026, to report other events. The filing does not contain specific financial figures or new material events beyond the reporting requirement.
Why It Matters
This filing indicates Senti Biosciences is fulfilling its reporting obligations with the SEC, but provides no new operational or financial information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for other events and does not disclose any new material risks or information.
Key Players & Entities
- Senti Biosciences, Inc. (company) — Filer
- 0001854270 (company) — CIK Number
- 2026-04-01 (date) — Filing Date
FAQ
What is the purpose of this 8-K filing?
The purpose of this 8-K filing is to report 'Other Events' as per Item 8.01 of the form.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 1, 2026, at 16:31:42.
What is Senti Biosciences, Inc.'s CIK number?
Senti Biosciences, Inc.'s CIK number is 0001854270.
What is the business address of Senti Biosciences, Inc.?
The business address of Senti Biosciences, Inc. is 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080.
Does this filing contain specific financial details or material new information?
No, this filing is categorized under 'Item 8.01: Other Events' and the provided document details do not indicate the disclosure of specific financial figures or new material events.
From the Filing
EDGAR Filing Documents for 0001628280-26-022824 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001628280-26-022824 Filing Date 2026-04-01 Accepted 2026-04-01 16:31:42 Documents 11 Period of Report 2026-04-01 Items Item 8.01: Other Events Interactive Data Document Format Files Seq Description Document Type Size 1 8-K snti-20260401.htm iXBRL 8-K 28482 Complete submission text file 0001628280-26-022824.txt 147355 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20260401.xsd EX-101.SCH 1785 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20260401_lab.xml EX-101.LAB 22530 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20260401_pre.xml EX-101.PRE 13045 14 EXTRACTED XBRL INSTANCE DOCUMENT snti-20260401_htm.xml XML 2835 Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 239-2030 Senti Biosciences, Inc. (Filer) CIK : 0001854270 (see all company filings) EIN. : 862437900 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 26828772 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)